The use of stem cells has been reported to improve hair regrowth in several therapeutic
strategies, including reversing the pathological mechanisms, that contribute to hair loss …

The field of hair disorders is constantly growing. The most important hair diseases are
divided in non‐cicatricial and cicatricial ones. Non‐cicatricial alopecia are more frequent …

Female androgenetic alopecia (FAGA) is a common cause of non-scarring alopecia in
women. The onset may be at any age following puberty and the frequency increases with …

Platelet rich plasma (PRP) was tested as a potential therapy for androgenetic alopecia
(AGA) through two different clinical protocols in which one population (18 participants) …

Platelet rich plasma (PRP) and Micrografts containing human follicle mesenchymal stem
cells (HF-MSCs) were tried as a potential treatment for androgenetic alopecia (AGA) …

Androgenetic alopecia (AGA) is the most common cause of hair loss in men and women.
Traditionally, topical minoxidil and oral finasteride have been the standard of care yielding …

Objective To determine the current state of knowledge and provide evidence-based
recommendations that could be valid for all specialists taking care of female pattern hair loss …

Alopecia is a dermatologic condition that affects the pilosebaceous unit in both men and
women. In addition to a thorough medical history and physical examination, a host of …

Androgenetic alopecia (AGA) is the most common nonscarring alopecia and is
characterised by distinct gradual patterned hair loss. AGA is mediated by genetic …

Androgenetic alopecia (AGA) is a hair loss disorder affecting 80% of men and 50% of
women throughout their lifetime. Therapies for AGA are limited and there is no cure. There is …